Crispr Therapeutics Ag (CRSP)

Operating Cash Flow Growth

26.68%

Quarterly · Period ending:

CRSP logo

CRSP Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported26.68%
CRSP Quarterly Cash from Operations YoY % (-532.60% → 26.68%)
High-resolution chart · PNG

CRSP operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
26.679%
-101.8592%
-84.9913%
20.8384%
-19.1438%
-149.1535%
47.924%
-168.2482%
28.266%
1,147.3236%
15.2257%
62.1205%
6.1364%
106.5063%
-31.7185%
-29.3733%
-117.5905%
-34.3483%
-5.9425%
-7.4359%
2,856.2485%
-92.9334%
-2,505.5687%
-156.7381%
19.5234%
-19.2926%
111.8991%
768.3029%
-44.2871%
-92.7759%
-91.1602%
-25.813%
-57.8404%
3.0924%
23.5579%
-29.2603%
-17.4287%
-133.7927%
-128.1375%
-131.0559%
-407.6119%
-532.5963%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.